Chronic kidney disease trials in China

In China 120 Also abroad 798

120 trials · From ClinicalTrials.gov, checked 12 November 2026. Ask the study team whether a trial fits you.

Phase 1/2Not yet taking people in China
Human Umbilical Cord Mesenchymal Stem Cell Infusion for Type 2 Diabetic Nephropathy
Where
Changzhou
Age
18 years to 80 years
People
49
Run by
The First People's Hospital of Changzhou
See details and how to joinNCT07769671
No phaseTaking people
A Prospecitve Multicenter, Observational Registry Study
Where
Anning, Yunnan - South Region, Beijing, Beijing, Cangzhou, Hebei - North Region, Caoxian County, Shandong Province, Changzhou, Jiangsu Province, Chengdu, Sichuan Province, Chongqing, Chongqing, Chongqing, Sichuan Province, Dalian, Liaoning, Dongguan, Guangdong, Foshan, Guangdong, Fuzhou, Fujian, Ganzhou, Jiangxi, Guangzhou, Guangdong, Guiyang, Guizhou, Hangzhou, Zhejiang, Harbin, Heilongjiang, Hohhot, Inner Mongolia, Huai An, Jiangsu Province, Jiaozuo, Henan Province, Jinan, Shandong Province, Jining, Shandong Province, Jiujiang, Jiangxi, Kunming, Yunnan, Nanchang, Jiangxi, Nanjing, Jiangsu Province, Nanning, Guangxi, Nanping, Fujian, Nantong, Jiangsu Province, Nanyang, Henan Province, Shanghai, Shanghai, Shangqiu, Henan Province, Shantou, Guangdong, Shaoxing, Zhejiang, Shenyang, Liaoning, Shenzhen, Guangdong, Shijiazhuang, Hebei, Suzhou, Jiangsu Province, Taiyuan, Shanxi, Taizhou, Jiangsu, Tianjin, Tianjin, Tonglu County, Zhejiang, Urumqi, Xinjiang, Weifang, Shandong Province, Wuhan, Hubei, Xiamen, Fujian, Xiangyang, Hubei, XI An, Shaanxi Province, Xiantao, Hubei, Xuancheng, Anhui, Yinchuan, Ningxia Hui Autonomous Region, Yiwu,Zhejiang, Zhangzhou, Fujian, Zhenjiang, Jiangsu Province, Zhoushan, Zhejiang, Zhuji, Zhejiang, Zibo, Shandong Province
People
3,000
Run by
AstraZeneca
See details and how to joinNCT07481526
No phaseTaking people
Real-World Study of Enarodustat for Anemia in Non-Dialysis CKD Patients
Where
Shanghai
Age
18 years to 85 years
People
90
Run by
Huashan Hospital
See details and how to joinNCT07741279
Phase 4Taking people
Niaoduqing Granules in Older Adults With Impaired Kidney Function
Where
Shanghai
Age
61 years and over
People
300
Run by
Huashan Hospital
See details and how to joinNCT07741292
Phase 3Taking people
Effect of Ketosteril on Sarcopenia in Patients With Chronic Kidney Disease
Where
Shanghai
People
58
Run by
Huashan Hospital
See details and how to joinNCT06329622
Phase 3Taking people
A Phase III Clinical Study on the Efficacy and Safety of HRS-1780 in the Treatment of Patients With Chronic Kidney Disease
Where
Nanjing
Age
18 years to 80 years
People
5,386
Run by
Shandong Suncadia Medicine Co., Ltd.
See details and how to joinNCT07419828
No phaseNot yet taking people in China
A Cohort Study on the Integrated Management of Chronic Kidney Disease
Where
Shanghai
Age
18 years to 90 years
People
4,029
Run by
Huashan Hospital
See details and how to joinNCT07712341
No phaseNot yet taking people in China
Evaluating the Effectiveness of a Smart Screening and Tiered Management Tool for Diabetic Kidney Disease in Primary Care: A Cluster Randomized Trial
Where
Chongqing
Age
18 years to 75 years
People
3,000
Run by
First Affiliated Hospital of Chongqing Medical University
See details and how to joinNCT07707518
Phase 2Taking people
A Mechanistic Study on the Effect of HTD1801 Versus Placebo on Kidney Function in Patients With Type 2 Diabetes and Chronic Kidney Disease.
Where
Weifang
Age
18 years to 75 years
People
75
Run by
Institute of Medicinal Biotechnology, Chinese Academy of Medical Sciences
See details and how to joinNCT07496177
Phase 2Taking people
Safety and Efficacy of Mesenchymal Stromal Cells (Amimestrocel ) in Diabetic Kidney Disease
Where
Beijing
Age
18 years to 80 years
People
120
Run by
Chinese PLA General Hospital
See details and how to joinNCT06969807
Phase 4Not yet taking people in China
Naoxintong Capsule for Diabetic Nephropathy With Dampness Retention Pattern: A Multicenter, Randomized, Double-Blind, Placebo-Controlled TrialAcronymNXT-DKD
Where
Beijing, Chongqing, Dalian, Hangzhou, Shanghai
Age
18 years and over
People
410
Run by
Chen Xiangmei
See details and how to joinNCT07698223
Phase 1Taking people
A Phase 1b Study to Evaluate the PK of CSL300 (Clazakizumab) in Chinese Subjects With End Stage Kidney Disease (ESKD)
Where
Beijing
Age
18 years and over
People
24
Run by
CSL Behring
See details and how to joinNCT07619820
No phaseTaking people
Efficacy of pHA130 Hemoadsorption on Protein-Bound Uremic Toxins and Quality of Life in Kidney Failure
Where
Beijing
Age
18 years and over
People
100
Run by
China-Japan Friendship Hospital
See details and how to joinNCT07656168
Phase 4Not yet taking people in China
Finerenone for Regression of Albuminuria in Type 2 Diabetes With Chronic Kidney Disease
Where
Chongqing, Foshan, Fuzhou, Guangzhou, Hangzhou, Nantong, Ningbo, Shanghai, Suqian, Suzhou, Wenzhou, Xi’an
Age
18 years and over
People
148
Run by
First Affiliated Hospital of Zhejiang University
See details and how to joinNCT07667517
No phaseTaking people
Coated Aldehyde Oxystarch for Protein-Bound Uremic Toxin Reduction in End-Stage Renal Disease
Where
Beijing
Age
18 years and over
People
30
Run by
Peking University People's Hospital
See details and how to joinNCT07653711
No phaseNot yet taking people in China
Clinical Study on the Efficacy and Safety of Nalfurafine Hydrochloride Orally Disintegrating Tablets in Treating Pruritus in Patients Undergoing Maintenance Hemodialysis
Where
Beijing
Age
18 years to 80 years
People
150
Run by
Chinese PLA General Hospital
See details and how to joinNCT07650851
Phase 2Not yet taking people in China
A Phase II Clinical Trial of Efficacy and Safety of SAL0140 at Different Doses in Patients With Chronic Kidney Disease
Where
Nanjing, Shenzhen
Age
18 years and over
People
249
Run by
Shenzhen Salubris Pharmaceuticals Co., Ltd.
See details and how to joinNCT07647133
No phaseTaking people
Theory-based Health Behaviour Change Intervention in Patients of Metabolic Syndrome With Chronic Kidney Disease
Where
Chengdu
Age
18 years and over
People
40
Run by
Chinese University of Hong Kong
See details and how to joinNCT06527768
Phase 3Not yet taking people in China
Renal Efficacy and Safety of the Novel Oral Small-Molecule GLP-1RA HRS-7535 Evaluated in Participants With Chronic Kidney Disease
Where
Hangzhou, Tianjin
Age
18 years and over
People
3,690
Run by
Shandong Suncadia Medicine Co., Ltd.
See details and how to joinNCT07625774
No phaseTaking people
Changes in Regional Ventilation-Perfusion Match Following Percutaneous Transluminal Angioplasty for Arteriovenous Graft Thrombosis
Where
Wuhu
Age
18 years and over
People
20
Run by
First Affiliated Hospital of Wannan Medical College
See details and how to joinNCT07613632
Phase 4Enrolling by invitation
Amino Acid (15) Peritoneal Dialysis Solution for Nutritional Improvement in Peritoneal Dialysis Patients
Where
Shanghai
Age
18 years and over
People
50
Run by
Shanghai 10th People's Hospital
See details and how to joinNCT07370441
Phase 2Not yet taking people in China
A Study of the Effect and Safety of HS-10390 in the Treatment of Participants With Chronic Kidney Disease
Where
Guangzhou
Age
18 years to 70 years
People
182
Run by
Jiangsu Hansoh Pharmaceutical Co., Ltd.
See details and how to joinNCT07555054
No phaseTaking people
Study on Construction of Whole Lifecycle Cohort, Big Data Management and Clinical Prognosis of Cardio-Renal-Metabolic (CKM) Syndrome
Where
Fuzhou
Age
18 years to 80 years
People
8,000
Run by
First Affiliated Hospital of Fujian Medical University
See details and how to joinNCT07547098
Early phase 1Taking people
CAR-T Therapy Targeting CD19 and BCMA in Highly Sensitized Kidney Transplant Participants
Where
Wuhan
Age
18 years to 65 years
People
12
Run by
Tongji Hospital
See details and how to joinNCT07350837
No phaseTaking people
Multimodal Magnetic Resonance Imaging in Evaluation of Diabetic Kidney Disease
Where
Shenyang
Age
18 years to 80 years
People
150
Run by
Shengjing Hospital
See details and how to joinNCT06452862